Los Angeles, CA -- (SBWire) -- 11/09/2018 --This report focuses on the global Metabolic Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolic Syndrome development in United States, Europe and China.Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.

One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.

In 2017, the global Metabolic Syndrome market size was 24600 million US$ and it is expected to reach 36700 million US$ by the end of 2025, with a CAGR of 5.1% during 2018-2025.

The key players covered in this study

Novo Nordisk

Sanofi

Merck

AstraZeneca

Eli Lily

AbbVie

Actelion Pharmaceuticals

Adocia

Aegerion Pharmaceuticals

Akros Pharma

Alnylam Pharmaceuticals

Amarin

nAmgen

Amicus Therapeutics

Arbutus Biopharma

Market segment by Type, the product can be split into

Diabetes

Obesity

Hypercholesterolemia

Lysosomal storage diseases

Market segment by Application, split into

Hospital

Clinic

Others

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/645661/global-metabolic-syndrome-market

Market size split by Region

-North America
-Asia-Pacific
-Europe
-Central & South America
-Middle East & Africa

Benefits of Purchasing QY Research Report

- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
-Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report

Buy Full market Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/d7ecb75ca5ab56457cf7eb6abd13ade0,0,1,Global%20Metabolic%20Syndrome%20Market%20Size%252C%20Status%20and%20Forecast%202018-2025

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.